Literature DB >> 18987270

Is obesity our genetic legacy?

Alexandra I F Blakemore1, Philippe Froguel.   

Abstract

CONTEXT: To design rational management regimes and identify novel therapeutic targets, it is essential to understand the biological drivers of the current epidemic of obesity. This review describes our current knowledge of genetic factors in obesity, drawing functional parallels in the underlying neuroendocrine mechanisms and suggesting promising new directions for research. EVIDENCE ACQUISITION: Published literature, addressing both the current knowledge of genetics of monogenic and syndromic forms of extreme obesity, and the emerging literature on genetic factors associated with more common forms of obesity are analyzed. EVIDENCE SYNTHESIS: The current genetic evidence in obesity underlines the importance of neuroendocrine mechanisms of appetite regulation. Monogenic forms of disease explain 6% of children with extreme obesity, having hyperphagia associated with defects in the leptin-melanocortin pathway, as a central feature. Candidate gene association studies indicate that more subtle variations of the same genes also contribute to common forms of obesity. Well-powered genome-wide association studies recently identified FTO as a strong contributor to both childhood and adult obesity, demonstrating the power of such hypothesis-free analysis to provide new insights into the underlying pathogenic mechanisms of a common complex disease.
CONCLUSIONS: Although there has been some very heartening recent progress in elucidating genetic mechanisms underlying obesity, we are still a long way from explaining the high heritability of adiposity. Investigations of different forms of variation, such as copy number polymorphism, may extend our understanding of this condition.

Entities:  

Mesh:

Year:  2008        PMID: 18987270     DOI: 10.1210/jc.2008-1676

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

Review 1.  From obesity genetics to the future of personalized obesity therapy.

Authors:  Julia S El-Sayed Moustafa; Philippe Froguel
Journal:  Nat Rev Endocrinol       Date:  2013-03-26       Impact factor: 43.330

2.  Obesity as a Socially Defined Disease: Philosophical Considerations and Implications for Policy and Care.

Authors:  Bjørn Hofmann
Journal:  Health Care Anal       Date:  2016-03

Review 3.  Behavioral and pharmacologic therapies for obesity.

Authors:  Marion L Vetter; Lucy F Faulconbridge; Victoria L Webb; Thomas A Wadden
Journal:  Nat Rev Endocrinol       Date:  2010-08-03       Impact factor: 43.330

4.  Evaluation of genetic susceptibility loci for obesity in Chinese women.

Authors:  Jiajun Shi; Jirong Long; Yu-Tang Gao; Wei Lu; Qiuyin Cai; Wanqing Wen; Ying Zheng; Kai Yu; Yong-Bing Xiang; Frank B Hu; Wei Zheng; Xiao-Ou Shu
Journal:  Am J Epidemiol       Date:  2010-07-08       Impact factor: 4.897

Review 5.  Ethical issues of obesity surgery--a health technology assessment.

Authors:  Samuli I Saarni; Heidi Anttila; Suoma E Saarni; Pertti Mustajoki; Vesa Koivukangas; Tuija S Ikonen; Antti Malmivaara
Journal:  Obes Surg       Date:  2011-09       Impact factor: 4.129

6.  New directions in childhood obesity research: how a comprehensive biorepository will allow better prediction of outcomes.

Authors:  Matthew A Sabin; Susan L Clemens; Richard Saffery; Zoe McCallum; Michele W Campbell; Wieland Kiess; Nancy A Crimmins; Jessica G Woo; Gary M Leong; George A Werther; Obioha C Ukoumunne; Melissa A Wake
Journal:  BMC Med Res Methodol       Date:  2010-10-22       Impact factor: 4.615

Review 7.  Effects of the FTO gene on lifestyle intervention studies in children.

Authors:  Tara Rendo; Adriana Moleres; Amelia Marti Del Moral
Journal:  Obes Facts       Date:  2009-12-10       Impact factor: 3.942

Review 8.  Functional implications of hypothalamic neurogenesis in the adult mammalian brain.

Authors:  Daniel A Lee; Seth Blackshaw
Journal:  Int J Dev Neurosci       Date:  2012-07-31       Impact factor: 2.457

9.  Effects of alternate fasting or very low calorie diet and low calorie diet on metabolic syndrome in severely obese patients.

Authors:  M Tančić-Gajić; S Vujović; M Vukčević; M Ivović; M Drezgić; Lv Marina; M Stojanović; Z Arizanović; A Nenezić; D Micić
Journal:  Hippokratia       Date:  2012-10       Impact factor: 0.471

10.  A functional, genome-wide evaluation of liposensitive yeast identifies the "ARE2 required for viability" (ARV1) gene product as a major component of eukaryotic fatty acid resistance.

Authors:  Kelly V Ruggles; Jeanne Garbarino; Ying Liu; James Moon; Kerry Schneider; Annette Henneberry; Jeff Billheimer; John S Millar; Dawn Marchadier; Mark A Valasek; Aidan Joblin-Mills; Sonia Gulati; Andrew B Munkacsi; Joyce J Repa; Dan Rader; Stephen L Sturley
Journal:  J Biol Chem       Date:  2013-11-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.